Drug ELGN-2112 for gut absorption problems in preterm babies
Part of Digestive system, Hormones & metabolism clinical trials.
This Phase 3 trial tests whether ELGN-2112 helps preterm babies absorb food from the intestines. It aims to improve intestinal malabsorption and check safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born early, between 26 and 32 weeks of pregnancy
- The pregnancy age estimate from mom’s dates and/or early ultrasound matches within about 2 weeks
- Baby weighs at least 500 grams at birth
- Baby is born as a single baby or a twin
- No listed exclusion conditions in the provided criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether ELGN-2112 is safe in babies born very early or smaller than expected before birth. It may help doctors understand how to better care for these high-risk newborns.
This trial studies a treatment made from special particles in donor breast milk, given to very early-born babies who are at risk of a serious gut infection called NEC. It aims to see if these particles can help protect their intestines.
This study looks at how the gut works in premature babies to better understand digestion and health. It may help improve care for newborns born early.
This study tests a monitoring tool to help doctors spot a serious gut problem in premature babies born before 32 weeks. If the tool works, it could lead to earlier treatment and better outcomes.
This trial tests if giving lactase enzyme supplements helps preterm babies (born at or before 32 weeks) tolerate their feedings better. If your baby was born early and started feeding within the first few days of life, this study may be a good fit.
This trial tests a new infant formula to see if it helps babies' digestion and overall gut health. The formula is the only food the baby gets during the study.
Hear when a new Intestinal Malabsorption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.